跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 133,037 条关于
“Long QT Syndrome Type 2”
全部
133,037
临床试验
99,618
药物
8,237
机构
1,590
资讯
23,592
5个月前
Thryv Therapeutics Initiates Phase 2/3 Trial for Long QT Syndrome Treatment, Receives FDA Fast Track Designation
15天前
Thryv Therapeutics licenses structurally distinct SGK1 inhibitors to expand into Parkinson's and Alzheimer's disease
去年
Thryv Therapeutics Unveils Breakthrough SGK1 Inhibitor Data for Heart Failure and Long QT Syndrome at ESC Congress 2025
去年
LQT-1213 Receives FDA Orphan Drug Designation for Long QT Syndrome Treatment
去年
Landmark DPP and DPPOS Studies Show Long-Term Benefits of Lifestyle Changes and Metformin in Diabetes Prevention
去年
Spruce Biosciences Reports Breakthrough Long-Term Data for TA-ERT in Rare Sanfilippo Syndrome Type B
去年
Sanofi Launches Long-term Safety Study for TZIELD in Stage 2 Type 1 Diabetes Patients
去年
AAVantgarde Reports Positive Phase 1/2 Data for Gene Therapy AAVB-081 in Usher Syndrome Type 1B
去年
Long-term Study Shows Sustained Benefits of NT-501 Cell Therapy for Macular Telangiectasia Type 2
去年
Ultragenyx's UX111 Gene Therapy Shows Promise in Sanfilippo Syndrome Type A
第 1 页,共 2360 页
上一页
下一页